4985
Earth Corporation
アース製薬
- Industry
- Chemicals
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Dec 2021
203,785
Dec 2022
152,339
Dec 2023
158,344
Dec 2024
169,278
Dec 2025
179,182
Operating profit(million JPY)
Dec 2021
10,667
Dec 2022
7,434
Dec 2023
6,370
Dec 2024
6,425
Dec 2025
8,087
Operating profit margin(%)
Dec 2021
5.23
Dec 2022
4.88
Dec 2023
4.02
Dec 2024
3.8
Dec 2025
4.51
Profit before tax(million JPY)
Dec 2021
10,963
Dec 2022
8,057
Dec 2023
6,563
Dec 2024
5,946
Dec 2025
8,075
Profit(million JPY)
Dec 2021
7,142
Dec 2022
5,303
Dec 2023
4,102
Dec 2024
3,475
Dec 2025
5,238
Total assets(million JPY)
Dec 2021
120,715
Dec 2022
124,489
Dec 2023
132,407
Dec 2024
135,636
Dec 2025
149,382
Cash and cash equivalents(million JPY)
Dec 2021
21,027
Dec 2022
14,772
Dec 2023
17,505
Dec 2024
16,775
Dec 2025
22,930
Cash flows from operating activities(million JPY)
Dec 2021
4,814
Dec 2022
3,901
Dec 2023
7,524
Dec 2024
13,964
Dec 2025
10,795
Cash flows from investing activities(million JPY)
Dec 2021
-3,220
Dec 2022
-6,266
Dec 2023
-10,135
Dec 2024
-5,280
Dec 2025
-3,759
Cash flows from financing activities(million JPY)
Dec 2021
-4,610
Dec 2022
-4,464
Dec 2023
4,893
Dec 2024
-9,901
Dec 2025
-1,016
Return on equity(%)
Dec 2021
12.4
Dec 2022
8.6
Dec 2023
6.3
Dec 2024
5.1
Dec 2025
7.3
Equity ratio(%)
Dec 2021
49.7
Dec 2022
50.4
Dec 2023
50.3
Dec 2024
50.8
Dec 2025
50.2
Earnings per share(JPY per share)
Dec 2021
323.76
Dec 2022
240.47
Dec 2023
185.57
Dec 2024
158.26
Dec 2025
240
Net assets per share(JPY per share)
Dec 2021
2,720.37
Dec 2022
2,846.07
Dec 2023
3,007.52
Dec 2024
3,162.24
Dec 2025
3,429.2
Dividend per share(JPY per share)
Dec 2021
118
Dec 2022
118
Dec 2023
118
Dec 2024
120
Dec 2025
125
Payout ratio(%)
Dec 2021
36.45
Dec 2022
49.07
Dec 2023
63.59
Dec 2024
75.82
Dec 2025
52.08
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.